Human Recombinant Insulin Market - Global Outlook and Forecast 2022-2028
Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver.Recombinant human insulin has a significant advantage over insulin from other animal sources. Patients can better absorb human insulin.It is also easier to manage allergies related to insulin intake.
This report contains market size and forecasts of Human Recombinant Insulin in global, including the following market information:
Global Human Recombinant Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Recombinant Insulin Market Sales, 2017-2022, 2023-2028, (K Litre)
Global top five Human Recombinant Insulin companies in 2021 (%)
The global Human Recombinant Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid-Acting Human Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Recombinant Insulin include Novo Nordisk, Eli Lilly and Company, Sanofi, Julphar Gulf Pharmaceutical Industries, Bioton, Gan & Lee Pharmaceuticals, Zhuhai United Laboratories, Biocon and Wanbang Biopharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Recombinant Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Recombinant Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Litre)
Global Human Recombinant Insulin Market Segment Percentages, by Type, 2021 (%)
Global Human Recombinant Insulin Market Segment Percentages, by Application, 2021 (%)
Global Human Recombinant Insulin Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Human Recombinant Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Recombinant Insulin revenues share in global market, 2021 (%)
Key companies Human Recombinant Insulin sales in global market, 2017-2022 (Estimated), (K Litre)
Key companies Human Recombinant Insulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Human Recombinant Insulin in global, including the following market information:
Global Human Recombinant Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Recombinant Insulin Market Sales, 2017-2022, 2023-2028, (K Litre)
Global top five Human Recombinant Insulin companies in 2021 (%)
The global Human Recombinant Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rapid-Acting Human Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Recombinant Insulin include Novo Nordisk, Eli Lilly and Company, Sanofi, Julphar Gulf Pharmaceutical Industries, Bioton, Gan & Lee Pharmaceuticals, Zhuhai United Laboratories, Biocon and Wanbang Biopharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Recombinant Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Recombinant Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Litre)
Global Human Recombinant Insulin Market Segment Percentages, by Type, 2021 (%)
- Rapid-Acting Human Insulin
- Regular (Short Acting) Insulin
- NPH (Intermediate Acting) Insulin
- Long-Acting Human Insulin
- Premixed Human Insulins Insulin
Global Human Recombinant Insulin Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Retail Pharmacy
- Online Pharmacies
- Other
Global Human Recombinant Insulin Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Human Recombinant Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Recombinant Insulin revenues share in global market, 2021 (%)
Key companies Human Recombinant Insulin sales in global market, 2017-2022 (Estimated), (K Litre)
Key companies Human Recombinant Insulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novo Nordisk
- Eli Lilly and Company
- Sanofi
- Julphar Gulf Pharmaceutical Industries
- Bioton
- Gan & Lee Pharmaceuticals
- Zhuhai United Laboratories
- Biocon
- Wanbang Biopharmaceuticals
- Dongbao Enterprise Group
- PeproTech
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Human Recombinant Insulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Recombinant Insulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN RECOMBINANT INSULIN OVERALL MARKET SIZE
2.1 Global Human Recombinant Insulin Market Size: 2021 VS 2028
2.2 Global Human Recombinant Insulin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Recombinant Insulin Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Recombinant Insulin Players in Global Market
3.2 Top Global Human Recombinant Insulin Companies Ranked by Revenue
3.3 Global Human Recombinant Insulin Revenue by Companies
3.4 Global Human Recombinant Insulin Sales by Companies
3.5 Global Human Recombinant Insulin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Recombinant Insulin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Recombinant Insulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Recombinant Insulin Players in Global Market
3.8.1 List of Global Tier 1 Human Recombinant Insulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Recombinant Insulin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Recombinant Insulin Market Size Markets, 2021 & 2028
4.1.2 Rapid-Acting Human Insulin
4.1.3 Regular (Short Acting) Insulin
4.1.4 NPH (Intermediate Acting) Insulin
4.1.5 Long-Acting Human Insulin
4.1.6 Premixed Human Insulins Insulin
4.2 By Type - Global Human Recombinant Insulin Revenue & Forecasts
4.2.1 By Type - Global Human Recombinant Insulin Revenue, 2017-2022
4.2.2 By Type - Global Human Recombinant Insulin Revenue, 2023-2028
4.2.3 By Type - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
4.3 By Type - Global Human Recombinant Insulin Sales & Forecasts
4.3.1 By Type - Global Human Recombinant Insulin Sales, 2017-2022
4.3.2 By Type - Global Human Recombinant Insulin Sales, 2023-2028
4.3.3 By Type - Global Human Recombinant Insulin Sales Market Share, 2017-2028
4.4 By Type - Global Human Recombinant Insulin Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Recombinant Insulin Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacies
5.1.5 Other
5.2 By Application - Global Human Recombinant Insulin Revenue & Forecasts
5.2.1 By Application - Global Human Recombinant Insulin Revenue, 2017-2022
5.2.2 By Application - Global Human Recombinant Insulin Revenue, 2023-2028
5.2.3 By Application - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
5.3 By Application - Global Human Recombinant Insulin Sales & Forecasts
5.3.1 By Application - Global Human Recombinant Insulin Sales, 2017-2022
5.3.2 By Application - Global Human Recombinant Insulin Sales, 2023-2028
5.3.3 By Application - Global Human Recombinant Insulin Sales Market Share, 2017-2028
5.4 By Application - Global Human Recombinant Insulin Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Recombinant Insulin Market Size, 2021 & 2028
6.2 By Region - Global Human Recombinant Insulin Revenue & Forecasts
6.2.1 By Region - Global Human Recombinant Insulin Revenue, 2017-2022
6.2.2 By Region - Global Human Recombinant Insulin Revenue, 2023-2028
6.2.3 By Region - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
6.3 By Region - Global Human Recombinant Insulin Sales & Forecasts
6.3.1 By Region - Global Human Recombinant Insulin Sales, 2017-2022
6.3.2 By Region - Global Human Recombinant Insulin Sales, 2023-2028
6.3.3 By Region - Global Human Recombinant Insulin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Recombinant Insulin Revenue, 2017-2028
6.4.2 By Country - North America Human Recombinant Insulin Sales, 2017-2028
6.4.3 US Human Recombinant Insulin Market Size, 2017-2028
6.4.4 Canada Human Recombinant Insulin Market Size, 2017-2028
6.4.5 Mexico Human Recombinant Insulin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Recombinant Insulin Revenue, 2017-2028
6.5.2 By Country - Europe Human Recombinant Insulin Sales, 2017-2028
6.5.3 Germany Human Recombinant Insulin Market Size, 2017-2028
6.5.4 France Human Recombinant Insulin Market Size, 2017-2028
6.5.5 U.K. Human Recombinant Insulin Market Size, 2017-2028
6.5.6 Italy Human Recombinant Insulin Market Size, 2017-2028
6.5.7 Russia Human Recombinant Insulin Market Size, 2017-2028
6.5.8 Nordic Countries Human Recombinant Insulin Market Size, 2017-2028
6.5.9 Benelux Human Recombinant Insulin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Recombinant Insulin Revenue, 2017-2028
6.6.2 By Region - Asia Human Recombinant Insulin Sales, 2017-2028
6.6.3 China Human Recombinant Insulin Market Size, 2017-2028
6.6.4 Japan Human Recombinant Insulin Market Size, 2017-2028
6.6.5 South Korea Human Recombinant Insulin Market Size, 2017-2028
6.6.6 Southeast Asia Human Recombinant Insulin Market Size, 2017-2028
6.6.7 India Human Recombinant Insulin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Recombinant Insulin Revenue, 2017-2028
6.7.2 By Country - South America Human Recombinant Insulin Sales, 2017-2028
6.7.3 Brazil Human Recombinant Insulin Market Size, 2017-2028
6.7.4 Argentina Human Recombinant Insulin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Recombinant Insulin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Recombinant Insulin Sales, 2017-2028
6.8.3 Turkey Human Recombinant Insulin Market Size, 2017-2028
6.8.4 Israel Human Recombinant Insulin Market Size, 2017-2028
6.8.5 Saudi Arabia Human Recombinant Insulin Market Size, 2017-2028
6.8.6 UAE Human Recombinant Insulin Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Human Recombinant Insulin Major Product Offerings
7.1.4 Novo Nordisk Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.1.5 Novo Nordisk Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Human Recombinant Insulin Major Product Offerings
7.2.4 Eli Lilly and Company Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Recombinant Insulin Major Product Offerings
7.3.4 Sanofi Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Julphar Gulf Pharmaceutical Industries
7.4.1 Julphar Gulf Pharmaceutical Industries Corporate Summary
7.4.2 Julphar Gulf Pharmaceutical Industries Business Overview
7.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Major Product Offerings
7.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.4.5 Julphar Gulf Pharmaceutical Industries Key News
7.5 Bioton
7.5.1 Bioton Corporate Summary
7.5.2 Bioton Business Overview
7.5.3 Bioton Human Recombinant Insulin Major Product Offerings
7.5.4 Bioton Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.5.5 Bioton Key News
7.6 Gan & Lee Pharmaceuticals
7.6.1 Gan & Lee Pharmaceuticals Corporate Summary
7.6.2 Gan & Lee Pharmaceuticals Business Overview
7.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Major Product Offerings
7.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.6.5 Gan & Lee Pharmaceuticals Key News
7.7 Zhuhai United Laboratories
7.7.1 Zhuhai United Laboratories Corporate Summary
7.7.2 Zhuhai United Laboratories Business Overview
7.7.3 Zhuhai United Laboratories Human Recombinant Insulin Major Product Offerings
7.7.4 Zhuhai United Laboratories Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.7.5 Zhuhai United Laboratories Key News
7.8 Biocon
7.8.1 Biocon Corporate Summary
7.8.2 Biocon Business Overview
7.8.3 Biocon Human Recombinant Insulin Major Product Offerings
7.8.4 Biocon Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.8.5 Biocon Key News
7.9 Wanbang Biopharmaceuticals
7.9.1 Wanbang Biopharmaceuticals Corporate Summary
7.9.2 Wanbang Biopharmaceuticals Business Overview
7.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Major Product Offerings
7.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.9.5 Wanbang Biopharmaceuticals Key News
7.10 Dongbao Enterprise Group
7.10.1 Dongbao Enterprise Group Corporate Summary
7.10.2 Dongbao Enterprise Group Business Overview
7.10.3 Dongbao Enterprise Group Human Recombinant Insulin Major Product Offerings
7.10.4 Dongbao Enterprise Group Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.10.5 Dongbao Enterprise Group Key News
7.11 PeproTech
7.11.1 PeproTech Corporate Summary
7.11.2 PeproTech Human Recombinant Insulin Business Overview
7.11.3 PeproTech Human Recombinant Insulin Major Product Offerings
7.11.4 PeproTech Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.11.5 PeproTech Key News
8 GLOBAL HUMAN RECOMBINANT INSULIN PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Recombinant Insulin Production Capacity, 2017-2028
8.2 Human Recombinant Insulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Recombinant Insulin Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN RECOMBINANT INSULIN SUPPLY CHAIN ANALYSIS
10.1 Human Recombinant Insulin Industry Value Chain
10.2 Human Recombinant Insulin Upstream Market
10.3 Human Recombinant Insulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Recombinant Insulin Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Human Recombinant Insulin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Recombinant Insulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HUMAN RECOMBINANT INSULIN OVERALL MARKET SIZE
2.1 Global Human Recombinant Insulin Market Size: 2021 VS 2028
2.2 Global Human Recombinant Insulin Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Recombinant Insulin Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Human Recombinant Insulin Players in Global Market
3.2 Top Global Human Recombinant Insulin Companies Ranked by Revenue
3.3 Global Human Recombinant Insulin Revenue by Companies
3.4 Global Human Recombinant Insulin Sales by Companies
3.5 Global Human Recombinant Insulin Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Recombinant Insulin Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Recombinant Insulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Recombinant Insulin Players in Global Market
3.8.1 List of Global Tier 1 Human Recombinant Insulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Recombinant Insulin Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Human Recombinant Insulin Market Size Markets, 2021 & 2028
4.1.2 Rapid-Acting Human Insulin
4.1.3 Regular (Short Acting) Insulin
4.1.4 NPH (Intermediate Acting) Insulin
4.1.5 Long-Acting Human Insulin
4.1.6 Premixed Human Insulins Insulin
4.2 By Type - Global Human Recombinant Insulin Revenue & Forecasts
4.2.1 By Type - Global Human Recombinant Insulin Revenue, 2017-2022
4.2.2 By Type - Global Human Recombinant Insulin Revenue, 2023-2028
4.2.3 By Type - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
4.3 By Type - Global Human Recombinant Insulin Sales & Forecasts
4.3.1 By Type - Global Human Recombinant Insulin Sales, 2017-2022
4.3.2 By Type - Global Human Recombinant Insulin Sales, 2023-2028
4.3.3 By Type - Global Human Recombinant Insulin Sales Market Share, 2017-2028
4.4 By Type - Global Human Recombinant Insulin Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Human Recombinant Insulin Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacies
5.1.5 Other
5.2 By Application - Global Human Recombinant Insulin Revenue & Forecasts
5.2.1 By Application - Global Human Recombinant Insulin Revenue, 2017-2022
5.2.2 By Application - Global Human Recombinant Insulin Revenue, 2023-2028
5.2.3 By Application - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
5.3 By Application - Global Human Recombinant Insulin Sales & Forecasts
5.3.1 By Application - Global Human Recombinant Insulin Sales, 2017-2022
5.3.2 By Application - Global Human Recombinant Insulin Sales, 2023-2028
5.3.3 By Application - Global Human Recombinant Insulin Sales Market Share, 2017-2028
5.4 By Application - Global Human Recombinant Insulin Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Human Recombinant Insulin Market Size, 2021 & 2028
6.2 By Region - Global Human Recombinant Insulin Revenue & Forecasts
6.2.1 By Region - Global Human Recombinant Insulin Revenue, 2017-2022
6.2.2 By Region - Global Human Recombinant Insulin Revenue, 2023-2028
6.2.3 By Region - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
6.3 By Region - Global Human Recombinant Insulin Sales & Forecasts
6.3.1 By Region - Global Human Recombinant Insulin Sales, 2017-2022
6.3.2 By Region - Global Human Recombinant Insulin Sales, 2023-2028
6.3.3 By Region - Global Human Recombinant Insulin Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Recombinant Insulin Revenue, 2017-2028
6.4.2 By Country - North America Human Recombinant Insulin Sales, 2017-2028
6.4.3 US Human Recombinant Insulin Market Size, 2017-2028
6.4.4 Canada Human Recombinant Insulin Market Size, 2017-2028
6.4.5 Mexico Human Recombinant Insulin Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Recombinant Insulin Revenue, 2017-2028
6.5.2 By Country - Europe Human Recombinant Insulin Sales, 2017-2028
6.5.3 Germany Human Recombinant Insulin Market Size, 2017-2028
6.5.4 France Human Recombinant Insulin Market Size, 2017-2028
6.5.5 U.K. Human Recombinant Insulin Market Size, 2017-2028
6.5.6 Italy Human Recombinant Insulin Market Size, 2017-2028
6.5.7 Russia Human Recombinant Insulin Market Size, 2017-2028
6.5.8 Nordic Countries Human Recombinant Insulin Market Size, 2017-2028
6.5.9 Benelux Human Recombinant Insulin Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Recombinant Insulin Revenue, 2017-2028
6.6.2 By Region - Asia Human Recombinant Insulin Sales, 2017-2028
6.6.3 China Human Recombinant Insulin Market Size, 2017-2028
6.6.4 Japan Human Recombinant Insulin Market Size, 2017-2028
6.6.5 South Korea Human Recombinant Insulin Market Size, 2017-2028
6.6.6 Southeast Asia Human Recombinant Insulin Market Size, 2017-2028
6.6.7 India Human Recombinant Insulin Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Recombinant Insulin Revenue, 2017-2028
6.7.2 By Country - South America Human Recombinant Insulin Sales, 2017-2028
6.7.3 Brazil Human Recombinant Insulin Market Size, 2017-2028
6.7.4 Argentina Human Recombinant Insulin Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Recombinant Insulin Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Recombinant Insulin Sales, 2017-2028
6.8.3 Turkey Human Recombinant Insulin Market Size, 2017-2028
6.8.4 Israel Human Recombinant Insulin Market Size, 2017-2028
6.8.5 Saudi Arabia Human Recombinant Insulin Market Size, 2017-2028
6.8.6 UAE Human Recombinant Insulin Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporate Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Human Recombinant Insulin Major Product Offerings
7.1.4 Novo Nordisk Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.1.5 Novo Nordisk Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Human Recombinant Insulin Major Product Offerings
7.2.4 Eli Lilly and Company Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Human Recombinant Insulin Major Product Offerings
7.3.4 Sanofi Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Julphar Gulf Pharmaceutical Industries
7.4.1 Julphar Gulf Pharmaceutical Industries Corporate Summary
7.4.2 Julphar Gulf Pharmaceutical Industries Business Overview
7.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Major Product Offerings
7.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.4.5 Julphar Gulf Pharmaceutical Industries Key News
7.5 Bioton
7.5.1 Bioton Corporate Summary
7.5.2 Bioton Business Overview
7.5.3 Bioton Human Recombinant Insulin Major Product Offerings
7.5.4 Bioton Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.5.5 Bioton Key News
7.6 Gan & Lee Pharmaceuticals
7.6.1 Gan & Lee Pharmaceuticals Corporate Summary
7.6.2 Gan & Lee Pharmaceuticals Business Overview
7.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Major Product Offerings
7.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.6.5 Gan & Lee Pharmaceuticals Key News
7.7 Zhuhai United Laboratories
7.7.1 Zhuhai United Laboratories Corporate Summary
7.7.2 Zhuhai United Laboratories Business Overview
7.7.3 Zhuhai United Laboratories Human Recombinant Insulin Major Product Offerings
7.7.4 Zhuhai United Laboratories Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.7.5 Zhuhai United Laboratories Key News
7.8 Biocon
7.8.1 Biocon Corporate Summary
7.8.2 Biocon Business Overview
7.8.3 Biocon Human Recombinant Insulin Major Product Offerings
7.8.4 Biocon Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.8.5 Biocon Key News
7.9 Wanbang Biopharmaceuticals
7.9.1 Wanbang Biopharmaceuticals Corporate Summary
7.9.2 Wanbang Biopharmaceuticals Business Overview
7.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Major Product Offerings
7.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.9.5 Wanbang Biopharmaceuticals Key News
7.10 Dongbao Enterprise Group
7.10.1 Dongbao Enterprise Group Corporate Summary
7.10.2 Dongbao Enterprise Group Business Overview
7.10.3 Dongbao Enterprise Group Human Recombinant Insulin Major Product Offerings
7.10.4 Dongbao Enterprise Group Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.10.5 Dongbao Enterprise Group Key News
7.11 PeproTech
7.11.1 PeproTech Corporate Summary
7.11.2 PeproTech Human Recombinant Insulin Business Overview
7.11.3 PeproTech Human Recombinant Insulin Major Product Offerings
7.11.4 PeproTech Human Recombinant Insulin Sales and Revenue in Global (2017-2022)
7.11.5 PeproTech Key News
8 GLOBAL HUMAN RECOMBINANT INSULIN PRODUCTION CAPACITY, ANALYSIS
8.1 Global Human Recombinant Insulin Production Capacity, 2017-2028
8.2 Human Recombinant Insulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Recombinant Insulin Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HUMAN RECOMBINANT INSULIN SUPPLY CHAIN ANALYSIS
10.1 Human Recombinant Insulin Industry Value Chain
10.2 Human Recombinant Insulin Upstream Market
10.3 Human Recombinant Insulin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Recombinant Insulin Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Human Recombinant Insulin in Global Market
Table 2. Top Human Recombinant Insulin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Recombinant Insulin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Recombinant Insulin Revenue Share by Companies, 2017-2022
Table 5. Global Human Recombinant Insulin Sales by Companies, (K Litre), 2017-2022
Table 6. Global Human Recombinant Insulin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Recombinant Insulin Price (2017-2022) & (USD/Litre)
Table 8. Global Manufacturers Human Recombinant Insulin Product Type
Table 9. List of Global Tier 1 Human Recombinant Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Recombinant Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 15. By Type - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 16. By Application – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 20. By Application - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 21. By Region – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 25. By Region - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 26. By Country - North America Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 29. By Country - North America Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 30. By Country - Europe Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 33. By Country - Europe Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 34. By Region - Asia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 37. By Region - Asia Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 38. By Country - South America Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 41. By Country - South America Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 42. By Country - Middle East & Africa Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 45. By Country - Middle East & Africa Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Human Recombinant Insulin Product Offerings
Table 48. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 49. Eli Lilly and Company Corporate Summary
Table 50. Eli Lilly and Company Human Recombinant Insulin Product Offerings
Table 51. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Human Recombinant Insulin Product Offerings
Table 54. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 55. Julphar Gulf Pharmaceutical Industries Corporate Summary
Table 56. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product Offerings
Table 57. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 58. Bioton Corporate Summary
Table 59. Bioton Human Recombinant Insulin Product Offerings
Table 60. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 61. Gan & Lee Pharmaceuticals Corporate Summary
Table 62. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product Offerings
Table 63. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 64. Zhuhai United Laboratories Corporate Summary
Table 65. Zhuhai United Laboratories Human Recombinant Insulin Product Offerings
Table 66. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 67. Biocon Corporate Summary
Table 68. Biocon Human Recombinant Insulin Product Offerings
Table 69. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 70. Wanbang Biopharmaceuticals Corporate Summary
Table 71. Wanbang Biopharmaceuticals Human Recombinant Insulin Product Offerings
Table 72. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 73. Dongbao Enterprise Group Corporate Summary
Table 74. Dongbao Enterprise Group Human Recombinant Insulin Product Offerings
Table 75. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 76. PeproTech Corporate Summary
Table 77. PeproTech Human Recombinant Insulin Product Offerings
Table 78. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 79. Human Recombinant Insulin Production Capacity (K Litre) of Key Manufacturers in Global Market, 2020-2022 (K Litre)
Table 80. Global Human Recombinant Insulin Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Human Recombinant Insulin Production by Region, 2017-2022 (K Litre)
Table 82. Global Human Recombinant Insulin Production by Region, 2023-2028 (K Litre)
Table 83. Human Recombinant Insulin Market Opportunities & Trends in Global Market
Table 84. Human Recombinant Insulin Market Drivers in Global Market
Table 85. Human Recombinant Insulin Market Restraints in Global Market
Table 86. Human Recombinant Insulin Raw Materials
Table 87. Human Recombinant Insulin Raw Materials Suppliers in Global Market
Table 88. Typical Human Recombinant Insulin Downstream
Table 89. Human Recombinant Insulin Downstream Clients in Global Market
Table 90. Human Recombinant Insulin Distributors and Sales Agents in Global Market
Table 1. Key Players of Human Recombinant Insulin in Global Market
Table 2. Top Human Recombinant Insulin Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Recombinant Insulin Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Recombinant Insulin Revenue Share by Companies, 2017-2022
Table 5. Global Human Recombinant Insulin Sales by Companies, (K Litre), 2017-2022
Table 6. Global Human Recombinant Insulin Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Recombinant Insulin Price (2017-2022) & (USD/Litre)
Table 8. Global Manufacturers Human Recombinant Insulin Product Type
Table 9. List of Global Tier 1 Human Recombinant Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Recombinant Insulin Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 15. By Type - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 16. By Application – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 20. By Application - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 21. By Region – Global Human Recombinant Insulin Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Recombinant Insulin Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Recombinant Insulin Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Recombinant Insulin Sales (K Litre), 2017-2022
Table 25. By Region - Global Human Recombinant Insulin Sales (K Litre), 2023-2028
Table 26. By Country - North America Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 29. By Country - North America Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 30. By Country - Europe Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 33. By Country - Europe Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 34. By Region - Asia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 37. By Region - Asia Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 38. By Country - South America Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 41. By Country - South America Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 42. By Country - Middle East & Africa Human Recombinant Insulin Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Recombinant Insulin Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Recombinant Insulin Sales, (K Litre), 2017-2022
Table 45. By Country - Middle East & Africa Human Recombinant Insulin Sales, (K Litre), 2023-2028
Table 46. Novo Nordisk Corporate Summary
Table 47. Novo Nordisk Human Recombinant Insulin Product Offerings
Table 48. Novo Nordisk Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 49. Eli Lilly and Company Corporate Summary
Table 50. Eli Lilly and Company Human Recombinant Insulin Product Offerings
Table 51. Eli Lilly and Company Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Human Recombinant Insulin Product Offerings
Table 54. Sanofi Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 55. Julphar Gulf Pharmaceutical Industries Corporate Summary
Table 56. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Product Offerings
Table 57. Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 58. Bioton Corporate Summary
Table 59. Bioton Human Recombinant Insulin Product Offerings
Table 60. Bioton Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 61. Gan & Lee Pharmaceuticals Corporate Summary
Table 62. Gan & Lee Pharmaceuticals Human Recombinant Insulin Product Offerings
Table 63. Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 64. Zhuhai United Laboratories Corporate Summary
Table 65. Zhuhai United Laboratories Human Recombinant Insulin Product Offerings
Table 66. Zhuhai United Laboratories Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 67. Biocon Corporate Summary
Table 68. Biocon Human Recombinant Insulin Product Offerings
Table 69. Biocon Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 70. Wanbang Biopharmaceuticals Corporate Summary
Table 71. Wanbang Biopharmaceuticals Human Recombinant Insulin Product Offerings
Table 72. Wanbang Biopharmaceuticals Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 73. Dongbao Enterprise Group Corporate Summary
Table 74. Dongbao Enterprise Group Human Recombinant Insulin Product Offerings
Table 75. Dongbao Enterprise Group Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 76. PeproTech Corporate Summary
Table 77. PeproTech Human Recombinant Insulin Product Offerings
Table 78. PeproTech Human Recombinant Insulin Sales (K Litre), Revenue (US$, Mn) and Average Price (USD/Litre) (2017-2022)
Table 79. Human Recombinant Insulin Production Capacity (K Litre) of Key Manufacturers in Global Market, 2020-2022 (K Litre)
Table 80. Global Human Recombinant Insulin Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Human Recombinant Insulin Production by Region, 2017-2022 (K Litre)
Table 82. Global Human Recombinant Insulin Production by Region, 2023-2028 (K Litre)
Table 83. Human Recombinant Insulin Market Opportunities & Trends in Global Market
Table 84. Human Recombinant Insulin Market Drivers in Global Market
Table 85. Human Recombinant Insulin Market Restraints in Global Market
Table 86. Human Recombinant Insulin Raw Materials
Table 87. Human Recombinant Insulin Raw Materials Suppliers in Global Market
Table 88. Typical Human Recombinant Insulin Downstream
Table 89. Human Recombinant Insulin Downstream Clients in Global Market
Table 90. Human Recombinant Insulin Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Human Recombinant Insulin Segment by Type
Figure 2. Human Recombinant Insulin Segment by Application
Figure 3. Global Human Recombinant Insulin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Recombinant Insulin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Recombinant Insulin Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Recombinant Insulin Sales in Global Market: 2017-2028 (K Litre)
Figure 8. The Top 3 and 5 Players Market Share by Human Recombinant Insulin Revenue in 2021
Figure 9. By Type - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Recombinant Insulin Price (USD/Litre), 2017-2028
Figure 12. By Application - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Recombinant Insulin Price (USD/Litre), 2017-2028
Figure 15. By Region - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 19. US Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 24. Germany Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 33. China Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 40. Brazil Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 44. Turkey Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Recombinant Insulin Production Capacity (K Litre), 2017-2028
Figure 49. The Percentage of Production Human Recombinant Insulin by Region, 2021 VS 2028
Figure 50. Human Recombinant Insulin Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Human Recombinant Insulin Segment by Type
Figure 2. Human Recombinant Insulin Segment by Application
Figure 3. Global Human Recombinant Insulin Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Recombinant Insulin Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Recombinant Insulin Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Recombinant Insulin Sales in Global Market: 2017-2028 (K Litre)
Figure 8. The Top 3 and 5 Players Market Share by Human Recombinant Insulin Revenue in 2021
Figure 9. By Type - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Recombinant Insulin Price (USD/Litre), 2017-2028
Figure 12. By Application - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 13. By Application - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 14. By Application - Global Human Recombinant Insulin Price (USD/Litre), 2017-2028
Figure 15. By Region - Global Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 19. US Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 24. Germany Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 33. China Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 40. Brazil Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Recombinant Insulin Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Recombinant Insulin Sales Market Share, 2017-2028
Figure 44. Turkey Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Recombinant Insulin Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Recombinant Insulin Production Capacity (K Litre), 2017-2028
Figure 49. The Percentage of Production Human Recombinant Insulin by Region, 2021 VS 2028
Figure 50. Human Recombinant Insulin Industry Value Chain
Figure 51. Marketing Channels
